Skip to main content

Women's Health

The clinical layer the urogynecologist and female-pelvic-medicine specialist often manages alongside the surgical problem — menopausal genitourinary changes, recurrent infection, sexual function, and the age-appropriate cancer-screening and risk-reduction decisions that shape preoperative counseling. For congenital reconstructive gynecology (MRKH, vaginal agenesis, McIndoe / Davydov / Vecchietti vaginoplasty), see Müllerian Anomalies & Vaginal Agenesis under Disorders of Genitalia.

Functional & Pelvic Floor​

  • Genitourinary Syndrome of Menopause (GSM)Pathophysiology, vaginal estrogen / DHEA / ospemifene formulation table, energy-based therapies, breast-cancer-survivor framework, AUA/SUFU/AUGS 2025 + NAMS 2020 anchors.
  • EndometriosisChronic estrogen-dependent inflammatory disease — clinical diagnosis without laparoscopy, OCP / progestin / oral GnRH antagonist (elagolix, relugolix combination) ladder, surgical recurrence framework, urologic involvement (bladder, ureter), and infertility / IVF integration.
  • Recurrent UTI2025 AUA / CUA / SUFU paradigm shift to non-antibiotic prevention, IBC / QIR pathway, vaginal estrogen first-line, methenamine and ALTAR / ImpresU evidence, ELIMINATE phage trial.
  • Female Sexual DysfunctionDSM-5 / ISSWSH disorder framework, ACOG evidence-graded recommendations, flibanserin / bremelanotide / transdermal testosterone data, mindfulness-based CBT.
  • Sexually Transmitted Infections2021 CDC treatment guidelines, 2024 doxy-PEP recommendations, USPSTF screening, NAAT diagnosis, PID and tubal-factor infertility sequelae, HPV vaccination, and pregnancy-specific management.

Cancer Screening & Risk Reduction​

  • Cancer ScreeningCervical (primary HPV, ASCCP risk-based management), breast (NCCN / USPSTF / ACR with Tyrer-Cuzick / BCSC stratification), and endometrial (no population screening; Lynch / tamoxifen / postmenopausal-bleeding workup) — the three cancers most often co-managed alongside female pelvic-floor surgery.
  • Opportunistic Adnexal SurgeryOpportunistic salpingectomy as primary prevention of tubo-ovarian carcinoma — tubal hypothesis, ACOG / ESGO / NCCN guidelines, SEE-FIM technique, ovarian-function evidence, expansion to non-gynecologic abdominopelvic surgery.
  • Osteoporosis ScreeningDXA timing, FRAX risk stratification, and post-menopausal pharmacotherapy overview — bone-health surveillance especially after BSO. Stub.